 | Up a level |
Salmanton-Garcia, Jon, Marchesi, Francesco 
ORCID: 0000-0001-6353-2272, Glenthoj, Andreas ORCID: 0000-0003-2082-0738, Bilgin, Yavuz M., van Praet, Jens, Davila-Valls, Julio, Martin-Perez, Sonia, Labrador, Jorge, van Doesum, Jaap, Falces-Romero, Iker, Farina, Francesca ORCID: 0000-0002-5124-6970, Schoenlein, Martin, Chanut, Mathilde, Petzer, Verena, Espigado, Ildefonso, Dargenio, Michelina, Aujayeb, Avinash, Sili, Uluhan, Serrano, Laura, Pinczes, Laszlo Imre, de Jonge, Nick, Soto-Silva, Andres, Buquicchio, Caterina, Prezioso, Lucia, Marchetti, Monia, Meers, Stef, Busca, Alessandro, Corradini, Paolo, Hoenigl, Martin, Koehler, Philipp, Rahimli, Laman, Colak, Gokce Melis, Arellano, Elena, Wolf, Dominik, Graefe, Stefanie, Ammatuna, Emanuele, Venemyr, Caroline Berg, Cornely, Oliver A. and Pagano, Livio
(2022).
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
Hemasphere, 6 (11).
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 2572-9241
Schoenlein, Martin, Wrage, Victoria, Ghandili, Susanne, Mellinghoff, Sibylle C., Brehm, Thomas Theo, Leypoldt, Lisa B., Utz, Nils, Schrader, Roland M., Alsdorf, Winfried, Boerschel, Niklas, Bussmann, Lara, Schoenrock, Martin, Perlick, Dorothea, Schoen, Gerhard, Verpoort, Karl, Luetgehetmann, Marc, zur Wiesch, Julian Schulze, Weisel, Katja C., Bokemeyer, Carsten, Schafhausen, Philippe and Sinn, Marianne (2022). Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study. Cancer Cell, 40 (6). S. 581 - 584. CAMBRIDGE: CELL PRESS. ISSN 1878-3686